| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc | Director | Ordinary Shares | 0 | $0 | $106.71 | 07 Oct 2025 | Direct |
| Verona Pharma plc | Director | Restricted Share Units | 96,000 | 25 Apr 2025 | Direct | ||
| Verona Pharma plc | Director | Restricted Stock Units | 72,000 | 01 Aug 2025 | Direct | ||
| Bolt Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 22,000 | 12 Jun 2024 | Direct | ||
| IMPEL PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 13,222 | 16 Jun 2023 | Direct | ||
| Verona Pharma plc | Director | Restricted Share Unit | 0 | 07 Oct 2025 | Direct | ||
| Verona Pharma plc | Director | Share Options (Right to Buy) | 0 | 07 Oct 2025 | Direct |